Clinical trial
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
Modified progression free survival (mPFS) per independent review facility (IRF)
| Category | Value |
|---|---|
| Study start date | 2012-11-22 |